Navigation Links
UB Neurosurgery Awarded Full Accreditation For Doppler Testing Of Carotid Artery Disease

Early detection of vascular disease by an accredited testing site provides doctors the essential information they need to properly manage the condition and prevent future stroke.

(Vocus) May 15, 2010 -- University at Buffalo Neurosurgery (UBNS) has been awarded full accreditation by the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL) for demonstrating excellence in patient care and commitment to vascular disease testing of the highest quality.

UBNS began in-house testing for vascular disease in August 2008 when it acquired a carotid Doppler machine to save patients the inconvenience of having to travel elsewhere for their imaging studies. Carotid Doppler is a safe, painless, and noninvasive ultrasound test used to monitor blood flow from the carotid arteries to the brain. Doppler images help physicians determine whether blood flow to the brain has been compromised by narrowed blood vessels due to plaque buildup. Evidence of extensive carotid narrowing may lead to a diagnosis of carotid artery disease (CAD)—a major risk factor for stroke.

Stroke, the third leading cause of death in the United States, occurs as a result of CAD when blood clots or dislodged plaque block the narrowed carotid artery, thereby interrupting blood flow to the brain. Carotid Doppler can detect CAD before a stroke occurs, giving doctors and patients the opportunity to determine if measures should be taken to prevent future stroke. If indicated, patients may undergo a minimally invasive carotid stenting procedure to widen the blocked artery and capture any dislodged plaque.

During the accreditation process, UBNS’ Doppler clinic was subjected to intense scrutiny of its protocol and quality assurance practices and evaluated for its overall impact on the quality of patient health. The clinic’s full accreditation status is a testament to its consistent delivery of outstanding patient care.

The ICAVL is a non-profit organization established with the support of eleven medical societies including physicians, technologists, and sonographers that represent medical specialties including cardiology, neurology, radiology, vascular medicine, vascular surgery, neurosurgery, internal medicine, and biology.    

About UBNS

University at Buffalo Neurosurgery (UBNS) is an academic neurosurgical group and leading regional referral center for cerebrovascular disorders run by a distinguished team of neurosurgical specialists and subspecialists committed to superior patient care, resident education, and translational research. UBNS diagnoses and treats a wide range of conditions, including but not limited to aneurysms; stroke; back and neck pain; epilepsy; Parkinson’s disease; hydrocephalus; and tumors of the brain, spine, and skull base. It is also the only neurosurgical group in Western New York with FDA approval to conduct device-related clinical trials for acute stroke. Visit for more information.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire the Center for Neurosurgery and Spine Near St. Cloud, Minn.
2. Lumenis Inc. Awarded a 3-year Dual Source Agreement with Novation
3. MU awarded $8.5 million to explore tiny vessels role in cardiovascular diseases
4. Therapure Awarded $4.2 Million BIP Grant from the Ontario Government
5. LA BioMed awarded research grant to study HIV prevention gel
6. £3M awarded for climate model to predict disease outbreak
7. Onyx M.D. Awarded GSA Schedule Contract Creating Increases Access to Government Physician Jobs
8. OHSU awarded $5.8 million to expand health information technology education
9. SWOG cancer trials network awarded over $120 million in NCI grants
10. Semel Institute awarded $15M to establish new integrative phenotyping center
11. Canadian research team awarded international grant for work on Indigenous peoples health
Post Your Comments:
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the first ... annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the International ... November 11th, 2015. The conference was held at the Hawaii Convention Center in ...
(Date:11/25/2015)... IN (PRWEB) , ... November 25, 2015 , ... ... water accessible for all, Water For Empowerment ™ attracts volunteers together who ... clean water by empowering women as key stakeholders in the process. The non-profit ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  The total global healthcare industry is expected to ... Latin America has the highest projected growth ... Japan ), is second with growth projected at ... increased healthcare expenditure. In 2013-2014, total government funded healthcare was ... 2008-2009 to 41.2% in 2013-2014. In real terms, out of ...
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
(Date:11/25/2015)... Kitov Pharma ceuticals ... biopharmaceutical company focused on the development of therapeutic candidates ... announced the closing of its previously announced underwritten public ... each representing 20 ordinary shares of the Company, and ... and warrants were issued in a fixed combination of ...
Breaking Medicine Technology: